Arthur G. Palmer and Oliver Hobert of the Department of Biochemistry & Molecular Biophysics were selected in recognition of their distinguished and continuing achievements in research.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
Columbia researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment.
Charels Drew, MD, earned his doctor of medical science degree at VP&S for research that led to the first large-scale blood bank program in the United States.
A combination of a diabetes drug and a PI3K inhibitor may have potential in preventing melanoma from spreading to the liver, according to a study from Columbia cancer researchers.
The CUIMC Healthy Aging Initiative will host its first Healthspan Extension Summit later this spring, highlighting the work of CUIMC researchers in basic, clinical, and population health sciences.
An inventor of new ways to manipulate molecules inside living cells to treat a wide range of conditions was inspired to become a scientist after reading the mysteries of Sherlock Holmes.
The Afternoon of Science series at the Vagelos College of Physicians and Surgeons continued Feb. 5 with presentations from Department of Biochemistry & Molecular Biophysics faculty.
A study led by Columbia and Cornell researchers finds, surprisingly, that anticoagulants do not prevent recurrent strokes in people with one type of heart condition.
A study from Columbia cancer researchers suggests drugs targeting the SMARCAL1 protein could strike a double blow against many cancers and make immunotherapy even more effective.